For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240712:nRSL2890Wa&default-theme=true
RNS Number : 2890W Elixirr International PLC 12 July 2024
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Director/PDMR Shareholding
Elixirr International plc (AIM:ELIX), an established, global award-winning
challenger consultancy, announces that certain Directors and PDMRs have
exercised options granted in May 2020 (the "Exercise") over ordinary shares in
the capital of the Company ("Ordinary Shares").
The Exercise has been satisfied from existing shares held in the Elixirr
International plc Employee Benefit Trust (the "EBT") and as a result there is
no dilution in the equity of the Company. No Directors or PDMRs are selling
any of the shares resulting from the option exercise other than in certain
cases, as set out below, where the EBT has purchased Ordinary Shares in order
to cover the exercise price (based on the closing mid-market price on 9 July
2024).
Following the Exercise, the EBT's beneficial holding is 732,433 Ordinary
Shares representing 1.5 per cent of the issued share capital of the Company.
Full details of the Exercise are detailed in the table below.
Director/PDMR Position Ordinary Shares transferred from EBT Ordinary Shares Sold Share Sale Price Resultant Holding % of total voting rights
Graham Busby Chief Financial Officer 94,000 7,102 574p 1,461,698 3.1%
Ian Ferguson Executive Director 15,600 - - 2,432,691 5.1%
Clare Filby Chief Operating Officer 172,800 13,055 574p 658,145 1.4%
Dieter Halfar Partner 94,000 7,102 574p 403,359 0.9%
Brandon Bichler Partner 177,858 - - 820,570 1.7%
Eric Rich Partner 185,429 - - 777,547 1.6%
For further information please contact:
Elixirr International plc
Stephen Newton, CEO
Graham Busby, CFO
Public and Investor Relations contacts:
investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)
Stephen Keys, Charlie Beeson (Corporate Finance)
Sunila de Silva (Corporate Broking) +44 (0) 20 7220 0500
Investec Bank plc (Joint Broker)
Carlton Nelson, Henry Reast (Corporate Broking) +44 (0) 20 7597 4000
About Elixirr International plc
Elixirr is an established global award-winning management consultancy,
challenging the larger consultancies by delivering innovative and bespoke
solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson,
Andy Curtis and Mark Goodyear, experienced business advisors who identified a
market opportunity to provide bespoke, personal services as a 'challenger' to
the traditional consultancy businesses in the market. Elixirr guides its
clients to overcome challenges such as: future-proofing against technological
disruption; development and roll-out of new propositions, products and
services; incubating new businesses; navigating a more complex and
multinational regulatory environment; and project management and
implementation of major change programmes.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Graham Busby
2. Clare Filby
3. Ian Ferguson
4. Dieter Halfar
5. Brandon Bichler
6. Eric Rich
2. Reason for the Notification
a) Position/status 1. Chief Financial Officer
2. Chief Operating Officer
3. Executive Director
4. Partner
5. Partner
6. Partner
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Elixirr International plc
b) LEI 213800MKY7OHMVAKW681
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of 0.005p each ("Ordinary Shares")
Identification code GB00BLPHTX84
b) Nature of the transaction Exercise of options over Ordinary Shares
c) Price(s) and volume(s) Director/PDMR Exercise Price(s) Volume(s)
Graham Busby 43.365p 94,000
Clare Filby 43.365p 172,800
Ian Ferguson 43.365p 15,600
Dieter Halfar 43.365p 94,000
Brandon Bichler 43.365p 177,858
Eric Rich 43.365p 185,429
d) Aggregated information:
· Aggregated volume As in 4c) above
· Price
e) Date of the transaction 12 July 2024
f) Place of the transaction Off market transaction
d)
Aggregated information:
· Aggregated volume
· Price
As in 4c) above
e)
Date of the transaction
12 July 2024
f)
Place of the transaction
Off market transaction
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1. Graham Busby
2. Clare Filby
3. Dieter Halfar
2. Reason for the Notification
a) Position/status 1. Chief Financial Officer
2. Chief Operating Officer
3. Partner
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Elixirr International plc
b) LEI 213800MKY7OHMVAKW681
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of 0.005p each ("Ordinary Shares")
Identification code GB00BLPHTX84
b) Nature of the transaction Sale of Ordinary Shares
c) Price(s) and volume(s) Director/PDMR Price(s) Volume(s)
Graham Busby 574p 7,102
Clare Filby 574p 13,055
Dieter Halfar 574p 7,102
d) Aggregated information:
· Aggregated volume As in 4c) above
· Price
e) Date of the transaction 12 July 2024
f) Place of the transaction Off market transaction
d)
Aggregated information:
· Aggregated volume
· Price
As in 4c) above
e)
Date of the transaction
12 July 2024
f)
Place of the transaction
Off market transaction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSFFFIEELSESW